Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria

被引：0
|
作者：
Karsten Weller [1 ]
Tonya Winders [2 ]
Jessica McCarthy [3 ]
Tara Raftery [4 ]
Pallavi Saraswat [5 ]
Cristina Constantinescu [6 ]
Maria-Magdalena Balp [7 ]
Jonathan A. Bernstein [8 ]
机构：
[1] Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin,Institute of Allergology, Charité – Universitätsmedizin Berlin
[2] Allergy and Asthma Network,Division of Rheumatology, Allergy and Immunology
[3] Global Allergy and Airways Patient Platform,undefined
[4] Novartis Pharmaceuticals Corporation,undefined
[5] Novartis Ireland Ltd.,undefined
[6] Novartis Healthcare Pvt. Ltd,undefined
[7] Ipsos SA,undefined
[8] Novartis Pharma AG,undefined
[9] University of Cincinnati,undefined
[10] Bernstein Allergy Group and Clinical Research Centre,undefined
来源：
Dermatology and Therapy | 2025年 / 15卷 / 3期
关键词：
Antihistamines; Angioedema; Chronic spontaneous urticaria; Disease/CU/symptom control; Physical symptoms; Psychological impact; Quality of life; Real world experience; Urticaria voices;
D O I：
10.1007/s13555-025-01348-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：747 / 761
页数：14
相关论文
共 50 条
  • [21] DIAGNOSTIC PATHWAY DIFFERENCES ACROSS PHYSICIAN SPECIALTIES FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: REAL-WORLD SURVEY
    Seetasith, A.
    Hetherington, J.
    Wrest, E.
    Keal, A.
    Salmon, P.
    Holden, M.
    Sibanda, D.
    Mosnaim, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S31 - S31
  • [22] ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
    Weller, Karsten
    Maurer, Marcus
    Grattan, Clive
    Nakonechna, Alla
    Abuzakouk, Mohamed
    Berard, Frederic
    Sussman, Gordon
    Gimenez-Arnau, Ana M.
    de Frutos, Javier Ortiz
    Knulst, Andre
    Canonica, G. Walter
    Hollis, Kelly
    McBride, Doreen
    Balp, Maria-Magdalena
    CLINICAL AND TRANSLATIONAL ALLERGY, 2015, 5
  • [23] A retrospective analysis of omalizumab treatment in patients with chronic spontaneous urticaria. A real-world study in Spain
    Laiseca, Garcia J.
    Gonzalez, Bravo L.
    Perez, Fernandez E.
    Perez, Codesido S.
    Privitera, Torres M.
    Brandoni, Petrone M. M.
    Tejedor, Alonso M. A.
    Rosado, Ingelmo A.
    ALLERGY, 2020, 75 : 324 - 325
  • [24] OMALIZUMAB TREATMENT OF CHRONIC SPONTANEOUS URTICARIA: EFFECTIVENESS AND SATISFACTION ASSESSED BY A REAL-WORLD SURVEY
    Casale, T.
    Seetasith, A.
    Hetherington, J.
    Hoskin, B.
    Wrest, E.
    Garmo, V.
    Holden, M.
    Bernstein, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S27 - S27
  • [25] What can be learned from real-world data about chronic spontaneous urticaria?
    Bakay, Ozge Sevil Karstarli
    Kacar, Nida
    Gul, Burak
    Goksin, Sule
    Gural, Yunus
    ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (04) : 255 - 261
  • [26] Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India
    Shah, Bela
    De, Abhishek
    Sarda, Aarti
    Kochhar, Atul M.
    Dhoot, Dhiraj
    Deshmukh, Gaurav
    Barkate, Hanmant
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [27] Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience
    Zhu, Catherine
    BinJadeed, Hessah
    Gabrielli, Sofianne
    Prosty, Connor
    Rahme, Elham
    Shand, Greg
    Fein, Michael
    Ben-Shoshan, Moshe
    Netchiporouk, Elena
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1227 - 1231
  • [28] REAL-WORLD TREATMENT PATTERNS OF OMALIZUMAB IN CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) PATIENTS IN THE UNITED STATES
    Eghrari-Sabet, J.
    Sher, E.
    Lefebvre, P.
    Pilon, D.
    Zhdanava, M.
    Balp, M.
    Kavati, A.
    Ortiz, B.
    Bernstein, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S42 - S42
  • [29] A retrospective analysis of omalizumab treatment patterns in patients with chronic spontaneous urticaria: Real-world evidence from Belgium
    Lapeere, H.
    Baeck, M.
    Stockman, A.
    Sabato, V
    Grosber, M.
    Moutschen, M.
    Rabijns, H.
    Allewaert, K.
    Schrijvers, R.
    ALLERGY, 2018, 73 : 225 - 225
  • [30] Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice survey
    Seetasith, Arpamas
    Holden, Michael
    Hetherington, James
    Keal, Aaron
    Salmon, Phoebe
    Bernstein, Jonathan A.
    Casale, Thomas B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (06) : 1059 - 1066
12345